JPRN-UMIN000020916招募中未知
Treatment with bevacizumab for ocular vascular lesions - Treatment with bevacizumab for ocular vascular lesions
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who cannot understand the impact of the study
研究者
相似试验
进行中（未招募）
不适用
Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration - NDViasual acuity lossMedDRA version: 9.1Level: SOCClassification code 10015919Term: Eye disordersEUCTR2006-004320-36-ITAZIENDA OSPEDALIERA SENESE
撤回
3 期
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal ChoroiditisNCT00407121Asociación para Evitar la Ceguera en México
已完成
不适用
Intravitreal bevacizumab treatment for severe retinopathy of prematuritysevere retinopathy of prematurityJPRN-UMIN000018122The Jikei University School of Medicine Department of Ophthalmology6
尚未招募
2 期
Role of subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after cornea TransplantCTRI/2021/10/037416SNMedical College
已完成
不适用
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30